These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 8730447)
1. Use of a phosphorus-enriched dialysate in a hypercatabolic renal failure patient receiving intensive hemodialysis therapy. Zabaneh RI; Bhatt DM; Yu AW; Tiwari P; Lai CI; Leehey DJ; Ing TS Nephron; 1996; 72(4):696-8. PubMed ID: 8730447 [TBL] [Abstract][Full Text] [Related]
2. Use of a phosphorus-enriched hemodialysate to prevent hypophosphatemia in a patient with renal failure-related pericarditis. Emelife-Obi C; Chow MT; Qamar-Rohail H; Leehey DJ; Gandhi VC; Ing TS Clin Nephrol; 1998 Aug; 50(2):131-3. PubMed ID: 9725787 [TBL] [Abstract][Full Text] [Related]
4. Hemodialysis-induced hypophosphatemia in a normophosphatemic patient dialyzed for ethylene glycol poisoning: treatment with phosphorus-enriched hemodialysis. Chow MT; Lin HJ; Mitra EA; Singh S; Lee E; Leehey DJ; Ing TS Artif Organs; 1998 Oct; 22(10):905-7. PubMed ID: 9790091 [TBL] [Abstract][Full Text] [Related]
5. Phosphorus-enriched hemodialysis during pregnancy: Two case reports. Hussain S; Savin V; Piering W; Tomasi J; Blumenthal S Hemodial Int; 2005 Apr; 9(2):147-52. PubMed ID: 16191063 [TBL] [Abstract][Full Text] [Related]
6. [Correction of the composition of the dialyzing solution during its electrochemical regeneration]. Maksimov EP; LeshchinskiÄ GM; Grinval'd VM; Fomicheva NN; Shadiev BSh Med Tekh; 2003; (2):8-10. PubMed ID: 12924213 [TBL] [Abstract][Full Text] [Related]
7. Effects of reduced dialysate calcium on calcium-phosphorus product and bone metabolism in hemodialysis patients. Fiedler R; Deuber HJ; Langer T; Osten B; Mohan S; Jehle PM Nephron Clin Pract; 2004; 96(1):c3-9. PubMed ID: 14752247 [TBL] [Abstract][Full Text] [Related]
8. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates. Elsharkawy MM; Youssef AM; Zayoon MY Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745 [TBL] [Abstract][Full Text] [Related]
9. The influence of dialysate calcium on the therapeutic effects of sevelamer hydrochloride in hemodialysis patients with secondary hyperparathyroidism under treatment of intravenous vitamin d metabolites. Ando R; Naito S; Inagaki Y; Hata T; Ishida Y; Chida Y; Takayama M; Tachibana K; Ohtsuka M; Inoue A Ther Apher Dial; 2005 Feb; 9(1):16-23. PubMed ID: 15828901 [TBL] [Abstract][Full Text] [Related]
10. Dialysate Calcium Concentration, Mineral Metabolism Disorders, and Cardiovascular Disease: Deciding the Hemodialysis Bath. Langote A; Ahearn M; Zimmerman D Am J Kidney Dis; 2015 Aug; 66(2):348-58. PubMed ID: 25958080 [TBL] [Abstract][Full Text] [Related]
11. Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance haemodialysis patients. Krautzig S; Janssen U; Koch KM; Granolleras C; Shaldon S Nephrol Dial Transplant; 1998 Mar; 13(3):552-3. PubMed ID: 9550625 [No Abstract] [Full Text] [Related]
12. Hemodialysis blood access flow rates can be estimated accurately from on-line dialysate urea measurements and the knowledge of effective dialyzer urea clearance. Lindsay RM; Sternby J; Olde B; Persson R; Thatcher ME; Sargent K Clin J Am Soc Nephrol; 2006 Sep; 1(5):960-4. PubMed ID: 17699313 [TBL] [Abstract][Full Text] [Related]
13. Dialysis fluid endotoxin level and mortality in maintenance hemodialysis: a nationwide cohort study. Hasegawa T; Nakai S; Masakane I; Watanabe Y; Iseki K; Tsubakihara Y; Akizawa T Am J Kidney Dis; 2015 Jun; 65(6):899-904. PubMed ID: 25641063 [TBL] [Abstract][Full Text] [Related]
14. High dialysate flow rate continuous arteriovenous hemodialysis: a new approach for the treatment of acute renal failure and tumor lysis syndrome. Pichette V; Leblanc M; Bonnardeaux A; Ouimet D; Geadah D; Cardinal J Am J Kidney Dis; 1994 Apr; 23(4):591-6. PubMed ID: 8154498 [TBL] [Abstract][Full Text] [Related]
15. Report of Dialysis-Induced Hypophosphatemia Leading to Reversible Encephalopathy Prevented by Adding Phosphorus to the Dialysate. Koganti D; Sam R Blood Purif; 2020; 49(4):496-501. PubMed ID: 31940631 [TBL] [Abstract][Full Text] [Related]
17. Correction of hypercalcemia and hypophosphatemia by hemodialysis using a conventional, calcium-containing dialysis solution enriched with phosphorus. Leehey DJ; Ing TS Am J Kidney Dis; 1997 Feb; 29(2):288-90. PubMed ID: 9016904 [TBL] [Abstract][Full Text] [Related]
18. Facility Dialysate Calcium Practices and Clinical Outcomes Among Patients Receiving Hemodialysis: A Retrospective Observational Study. Brunelli SM; Sibbel S; Do TP; Cooper K; Bradbury BD Am J Kidney Dis; 2015 Oct; 66(4):655-65. PubMed ID: 26015274 [TBL] [Abstract][Full Text] [Related]
19. Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients - a prospective cross-over study. Hsu PY; Lin CL; Yu CC; Chien CC; Hsiau TG; Sun TH; Huang LM; Yang CW J Nephrol; 2004; 17(5):693-700. PubMed ID: 15593037 [TBL] [Abstract][Full Text] [Related]